A survey sought to clarify teens' perceptions of recreational use of prescription drugs.
Multiple new drugs for pain management have been recently introduced or approved, and additional agents are currently under investigation.
A growing body of research is showing the importance of bolstering resilience in chronic pain management.
Treatment of neuroinflammation as the underlying cause of chronic, severe pain involves several components: standard pain relief, neuroinflammation control, spinal flow exercises, and neuroregeneration.
Dr Witzeman focused on integrative modalities for the treatment of female chronic pelvic pain.
At PAINWeek 2017, the president of the National Association of Drug Diversion Investigators discussed ways to balance pain management needs and overdose prevention measures.
At PAINWeek 2017, Dr Joshi gave on overview of stem cell therapies used in regenerative medicine to treat a number of pain conditions.
In patients with concomitant fibromyalgia and PTSD, opioid therapy was shown to improve quality of life and help patients return to a greater sense of "normalcy."
Participation in a pilot functional medicine clinic decreased perceived stress and joint and muscle symptoms in veterans with chronic pain.
In patients with opioid-induced constipation, naldemedine was shown to improve patient assessment of symptoms and quality of life.
Administration of abuse-deterrent formulations of immediate-release oxycodone and extended-release morphine leads to slower and lower absorption rates in nondependent recreational drug users compared with standard oxycodone and morphine formulations.
Opioid treatment of acute postoperative pain was shown to cause high rates of postoperative nausea and vomiting, particularly in women and younger patients.
Dr Gould covered the risks of co-prescribing benzodiazepines and opioids, particularly for elderly patients, and proposed therapeutic alternatives at PAINWeek 2017.
Dr Zacharoff provided advice for clinicians dealing with fluid guidelines and constraints regarding opioid prescribing.
Effective coaching strategies for the management of complicated pain were presented.
Dr McMaster gave an overview of differential diagnostic studies for pain pathologies, their utility in the clinic, and their limitations.
Dr Tick presented evidence linking nutrition, microbial diversity, and pain.
Dr Cuevas-Trisan covered the evaluation and management of diabetic peripheral neuropathic pain during his presentation at PAINWeek 2017.
Jennifer Bolen, JD, provides PAINWeek 2017 attendees with information on risk reduction and response to medication overdose events.
Dr Clark sought to outline a comprehensive approach to the assessment and follow-up of patients with chronic pain.
Sign Up for Free e-Newsletters
Check out what's trending
Clinical Pain Advisor Articles
- Sustained-Release Sodium Nitrite for Diabetic Neuropathic Pain Not Associated With Headaches
- Treatment for Opioid Use Disorder Associated With Reduced Risk for Opioid-Related Deaths
- Deaths After Nonfatal Opioid Overdose: Causes and Risk Factors
- Clonidine May Not Improve Post-Cesarean Delivery Analgesia
- No Added Value With Liposomal Bupivacaine Following TKA With Peripheral Nerve Block
- Recommendations for Perioperative Pain Management in Patients With Opioid Tolerance
- Vertebroplasty Comparable With Placebo for Acute Vertebral Compression Fractures
- Capsaicin 8% Patch May Be Effective in Neuropathic Pain
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Prior Authorization Policy May Help Reduce Long-Acting Opioid Use
- Opioid-Related Deaths Represent Significant Public Health Burden
- Addressing Confidentiality Concerns With Electronic Access to Pediatric Medical Records
- Opioid-Related Adverse Events Common After Invasive Procedures
- Diagnosis and Treatment of Migraine in Children Should Consider Atopy
- Led by AG Sessions, DOJ Declines to Defend ACA Against Federal Lawsuit